CC, W., JY, L., CY, W., WJ, S., PC, L., YF, H., . . . WJ, W. (2025). DSG2 attenuates gemcitabine efficacy through PTX3 in lung adenocarcinoma. Biochimica et biophysica acta. Molecular basis of disease, 1871(6), 167881. https://doi.org/10.1016/j.bbadis.2025.167881
Chicago Style (17th ed.) CitationCC, Wang, et al. "DSG2 Attenuates Gemcitabine Efficacy Through PTX3 in Lung Adenocarcinoma." Biochimica Et Biophysica Acta. Molecular Basis of Disease 1871, no. 6 (2025): 167881. https://doi.org/10.1016/j.bbadis.2025.167881.
MLA (9th ed.) CitationCC, Wang, et al. "DSG2 Attenuates Gemcitabine Efficacy Through PTX3 in Lung Adenocarcinoma." Biochimica Et Biophysica Acta. Molecular Basis of Disease, vol. 1871, no. 6, 2025, p. 167881, https://doi.org/10.1016/j.bbadis.2025.167881.